X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ACTAVIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
ACTAVIS
Dec-14
UNICHEM LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38218,957-   
Low Rs23411,563-   
Sales per share (Unadj.) Rs116.33,413.6-  
Earnings per share (Unadj.) Rs-18.9-426.0-  
Cash flow per share (Unadj.) Rs-11.7313.2-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.07,404.0-  
Shares outstanding (eoy) m70.34265.90-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.64.5 59.3%   
Avg P/E ratio x-16.3-35.8 45.4%  
P/CF ratio (eoy) x-26.248.7 -53.9%  
Price / Book Value ratio x0.82.1 39.2%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6684,057,635 0.5%   
No. of employees `0002.321.6 10.6%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.842,022.1 8.5%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.7-5,243.9 11.1%   
INCOME DATA
Net Sales Rs m8,180907,678 0.9%  
Other income Rs m610-2,265 -26.9%   
Total revenues Rs m8,790905,413 1.0%   
Gross profit Rs m-1,320116,604 -1.1%  
Depreciation Rs m505196,546 0.3%   
Interest Rs m8028,630 0.3%   
Profit before tax Rs m-1,295-110,837 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-8,130 0.0%   
Tax Rs m33-5,698 -0.6%   
Profit after tax Rs m-1,331-113,269 1.2%  
Gross profit margin %-16.112.8 -125.6%  
Effective tax rate %-2.65.1 -50.2%   
Net profit margin %-16.3-12.5 130.4%  
BALANCE SHEET DATA
Current assets Rs m23,318478,230 4.9%   
Current liabilities Rs m4,635348,770 1.3%   
Net working cap to sales %228.414.3 1,601.3%  
Current ratio x5.01.4 366.9%  
Inventory Days Days12258 209.9%  
Debtors Days Days12166 183.3%  
Net fixed assets Rs m8,163110,837 7.4%   
Share capital Rs m1410-   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,8011,968,721 1.4%   
Long term debt Rs m31,031,649 0.0%   
Total assets Rs m31,8903,608,018 0.9%  
Interest coverage x-15.2-2.9 528.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.3 102.0%   
Return on assets %-3.9-2.3 167.2%  
Return on equity %-5.0-5.8 86.3%  
Return on capital %-4.5-3.0 150.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,123155,866 -0.7%  
From Investments Rs m16,487-373,203 -4.4%  
From Financial Activity Rs m-8,811209,686 -4.2%  
Net Cashflow Rs m6,552-7,651 -85.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.49 Rs / USD

Compare UNICHEM LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: AJANTA PHARMA  SUN PHARMA  ORCHID PHARMA LTD  VENUS REMEDIES  AUROBINDO PHARMA  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views On News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 24, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS